Diethylpropion Hydrochloride Er

The dosage of Diethylpropion must be individualized to achieve the maximum therapeutic response with the lowest effective dose. Your healthcare provider will determine the most appropriate schedule for you.

• Immediate-Release (25 mg tablets): The standard dosage is one 25 mg tablet taken three times daily, approximately one hour before meals. If hunger occurs in the evening, an additional 25 mg dose may be prescribed mid-evening by your physician.
• Controlled-Release (75 mg tablets): The standard dosage is one 75 mg tablet taken once daily, usually at mid-morning (around 10:00 AM). This formulation is designed to provide appetite suppression throughout the day and evening. The tablet must be swallowed whole and never crushed, chewed, or split, as this would destroy the controlled-release mechanism and lead to a rapid, potentially dangerous release of the medication.

Diethylpropion is not recommended for use in pediatric patients under the age of 16. The safety and effectiveness of the drug in children have not been established, and the potential for CNS stimulation and growth suppression makes its use in this population generally inappropriate. If a teenager aged 16 or older is prescribed this medication, they must be monitored closely by a specialist in adolescent obesity.

Renal Impairment

Since Diethylpropion and its metabolites are primarily excreted by the kidneys, there is an increased risk of toxic reactions in patients with impaired renal function. While specific dosage adjustment formulas (like those based on CrCl) are not provided in the standard labeling, healthcare providers are advised to exercise extreme caution. In cases of severe renal impairment, the drug may be contraindicated or the frequency of dosing significantly reduced.

Hepatic Impairment

Although the liver is the primary site of metabolism, there are no specific guidelines for dosage adjustment in patients with hepatic impairment. However, because the drug is converted into active metabolites in the liver, altered liver function could theoretically affect the drug's efficacy and safety profile. Patients with liver disease should be monitored closely.

Elderly Patients

Clinical studies of Diethylpropion did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

To ensure the best results and minimize side effects, follow these instructions:

• Timing: Take the immediate-release tablets one hour before meals. Take the controlled-release tablet at mid-morning.
• Administration: Swallow the controlled-release tablet whole with a full glass of water. Do not crush or chew it.
• Diet and Exercise: Diethylpropion is most effective when used as part of a lifestyle modification program. Continue to follow the meal plan and exercise routine recommended by your doctor.
• Late Doses: Avoid taking Diethylpropion late in the evening, as it may cause insomnia (difficulty sleeping).
• Storage: Store the medication at room temperature (20°C to 25°C or 68°F to 77°F), away from moisture, heat, and direct light.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, or if it is late in the evening, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up, as this increases the risk of cardiovascular side effects and overstimulation.

An overdose of Diethylpropion can be life-threatening. Symptoms of acute overdose include:

• Extreme restlessness and tremor
• Rapid breathing (tachypnea)
• Confusion, aggression, or hallucinations
• Panic states
• Irregular heartbeat (arrhythmias) or high/low blood pressure
• Nausea, vomiting, and abdominal cramps
• Seizures or coma

In the event of a suspected overdose, seek emergency medical attention immediately or contact a poison control center. Treatment typically involves supportive care, sedation, and monitoring of cardiovascular function.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking the medication without medical guidance, as sudden discontinuation after prolonged use can lead to withdrawal symptoms.

Most patients taking Diethylpropion will experience some level of mild side effects as the body adjusts to the sympathomimetic activity. These often include:

• Xerostomia (Dry Mouth): A very common effect where the mouth feels parched. This occurs because the drug can decrease salivary flow. Staying hydrated or using sugar-free lozenges can help.
• Insomnia: Difficulty falling or staying asleep is common, especially if the medication is taken late in the day. This is due to the drug's stimulant effects on the central nervous system.
• Nervousness or Jitteriness: A feeling of being 'on edge' or having excess energy, similar to consuming too much caffeine.
• Constipation: A decrease in bowel movement frequency, often managed by increasing dietary fiber and fluid intake.

• Tachycardia: An abnormally rapid heart rate. Patients may feel their heart racing even while at rest.
• Palpitations: A sensation that the heart is skipping a beat, fluttering, or beating too hard.
• Increased Blood Pressure: Diethylpropion can cause a modest rise in both systolic and diastolic blood pressure.
• Dizziness: A feeling of lightheadedness or unsteadiness, particularly when standing up quickly.
• Mydriasis: Dilation of the pupils, which may cause sensitivity to light.
• Unpleasant Taste: A metallic or bitter taste in the mouth (dysgeusia).

• Psychotic Episodes: In rare cases, especially with higher-than-recommended doses, patients may experience hallucinations, paranoia, or extreme confusion.
• Dermatological Reactions: Rashes, hives (urticaria), or red spots on the skin (ecchymosis).
• Changes in Libido: Increased or decreased sexual drive, or impotence.
• Gastrointestinal Distress: Severe stomach pain, diarrhea, or persistent nausea.

> Warning: Stop taking Diethylpropion and call your doctor immediately or seek emergency care if you experience any of the following:

• Pulmonary Hypertension: This is a rare but potentially fatal condition characterized by high blood pressure in the arteries of the lungs. Symptoms include shortness of breath (dyspnea) during exertion, chest pain, fainting (syncope), and swelling in the ankles or legs.
• Valvular Heart Disease: Some anorectic drugs have been linked to damage to the heart valves. Symptoms include unusual tiredness, shortness of breath, and heart murmurs detected by a physician.
• Chest Pain (Angina): Any sensation of pressure, squeezing, or pain in the chest could indicate cardiovascular strain.
• Severe Allergic Reaction: Signs of anaphylaxis, including swelling of the face, lips, or tongue, difficulty breathing, or severe skin rash.
• Seizures: Any history of convulsions or new-onset seizure activity requires immediate discontinuation.

Diethylpropion is not intended for long-term use. If taken for extended periods, the following may occur:

• Tolerance: The weight-loss effects may stop as the body becomes accustomed to the drug. Increasing the dose to overcome tolerance is dangerous and strictly prohibited.
• Dependence and Addiction: As a Schedule IV controlled substance, Diethylpropion carries a risk of psychological and physical dependence. Abruptly stopping the drug after long-term use can lead to a 'crash,' characterized by extreme fatigue and mental depression.
• Chronic Insomnia: Prolonged use can lead to significant sleep disturbances that may persist after the drug is stopped.

No FDA black box warnings for Diethylpropion. However, the medication's labeling contains significant warnings regarding the risk of pulmonary hypertension and the potential for abuse and dependence, which carry similar clinical weight to black box warnings in practice.

Report any unusual symptoms to your healthcare provider. Monitoring your heart rate and blood pressure regularly while on this medication is highly recommended.

Diethylpropion is a potent medication that must be used with caution. It is a Schedule IV controlled substance, meaning it has a potential for abuse, though lower than Schedule II stimulants like amphetamines. Patients with a history of drug or alcohol abuse should be monitored with extreme care or avoided entirely. Because the drug can increase heart rate and blood pressure, it is not suitable for everyone, particularly those with pre-existing cardiovascular conditions.

No FDA black box warnings for Diethylpropion. While it lacks a formal black box warning, the 'Warnings' and 'Precautions' sections of the FDA-approved label emphasize that Diethylpropion should not be used in patients with a history of cardiovascular disease or severe hypertension.

• Pulmonary Hypertension: There have been rare reports of primary pulmonary hypertension (PPH) in patients receiving Diethylpropion. This is a serious, often fatal lung disease. If you experience a sudden decrease in exercise tolerance or new shortness of breath, notify your doctor immediately.
• Valvular Heart Disease: Serious regurgitant cardiac valvular disease has been reported in patients using certain anorectic agents. While Diethylpropion's link is less clear than other drugs (like fenfluramine), the risk cannot be entirely ruled out.
• Cardiovascular Effects: Diethylpropion may increase blood pressure and heart rate. It should be used with caution in patients with even mild hypertension. Regular monitoring is essential.
• CNS Effects: The drug may cause dizziness, tremors, and lightheadedness. It can also mask symptoms of extreme fatigue.
• Seizure Disorders: Diethylpropion may lower the seizure threshold. Patients with a history of epilepsy or other seizure disorders should generally avoid this medication.
• Psychological Effects: Patients with a history of mental health disorders, such as depression or psychosis, may experience a worsening of their condition. Monitor for signs of agitation or unusual behavior.

Before and during treatment with Diethylpropion, your healthcare provider may require the following:

• Blood Pressure and Pulse: These should be checked before starting the drug and at regular intervals during therapy.
• Baseline Cardiac Evaluation: In some cases, an echocardiogram may be recommended if there is a suspicion of underlying heart disease.
• Weight Monitoring: To ensure the drug is effective and to determine when tolerance has developed (indicating the drug should be stopped).
• Renal Function Tests: Especially in older patients, to ensure the kidneys are effectively clearing the drug.

Diethylpropion may impair your ability to perform potentially hazardous activities, such as driving or operating heavy machinery. The CNS effects, including dizziness and blurred vision, can occur unexpectedly. Do not drive or operate machinery until you know how the medication affects you.

Alcohol should be avoided while taking Diethylpropion. The combination can increase the risk of adverse CNS effects, such as dizziness and confusion. Furthermore, alcohol provides 'empty calories' that counteract the goals of a weight-loss program.

If you have been taking Diethylpropion for several weeks, do not stop taking it suddenly without consulting your doctor. While it is not as prone to withdrawal as stronger stimulants, a gradual reduction in dose (tapering) may be necessary to prevent extreme fatigue or depression. If the drug is no longer effective (tolerance), it should be discontinued rather than increasing the dose.

> Important: Discuss all your medical conditions, especially heart problems, high blood pressure, or a history of drug abuse, with your healthcare provider before starting Diethylpropion.

• Monoamine Oxidase Inhibitors (MAOIs): Diethylpropion must never be used within 14 days of taking an MAOI (such as phenelzine, selegiline, or tranylcypromine). Combining these can lead to a hypertensive crisis—a sudden, life-threatening rise in blood pressure that can cause a stroke or heart attack.
• Other Anorectics: Do not use Diethylpropion in combination with other weight-loss drugs, including over-the-counter herbal supplements for weight loss. The risk of pulmonary hypertension and valvular heart disease is significantly increased with 'polypharmacy' in weight management.

• Antihypertensive Agents: Diethylpropion may decrease the effectiveness of medications used to lower blood pressure, such as guanethidine or methyldopa. This occurs because Diethylpropion stimulates the sympathetic nervous system, which directly opposes the action of these drugs.
• Insulin and Oral Antidiabetics: As patients lose weight while taking Diethylpropion, their requirements for insulin or oral diabetes medications (like metformin or glipizide) may change. Close monitoring of blood glucose is required to prevent hypoglycemia (low blood sugar).
• Selective Serotonin Reuptake Inhibitors (SSRIs): While primarily noradrenergic, Diethylpropion used with drugs like fluoxetine or sertraline may increase the risk of CNS stimulation or, rarely, serotonin syndrome.

• Tricyclic Antidepressants (TCAs): Drugs like amitriptyline may potentiate the cardiovascular effects of Diethylpropion, leading to higher blood pressure and heart rate.
• General Anesthetics: If you are scheduled for surgery, inform your surgeon that you are taking Diethylpropion. There is a risk of cardiac arrhythmias during anesthesia due to the drug's effect on heart sensitivity.

• Caffeine: High intake of caffeine (coffee, tea, energy drinks) can have an additive effect with Diethylpropion, leading to excessive nervousness, insomnia, and a rapid heart rate. It is best to limit caffeine intake during treatment.
• High-Fat Meals: While food does not significantly alter the total absorption of Diethylpropion, taking the immediate-release form with a very heavy meal may slightly delay the onset of the appetite-suppressant effect.

• Ephedra/Ma Huang: This combination is extremely dangerous and can lead to severe cardiovascular events, including stroke.
• St. John's Wort: May increase the risk of CNS side effects.
• Stimulant Supplements: Avoid any 'pre-workout' or 'fat-burner' supplements containing synephrine, caffeine, or other stimulants.

Diethylpropion may interfere with urine drug screenings. Because it is chemically related to amphetamines, it may cause a 'false positive' for amphetamines on some rapid screening tests. If you are undergoing a drug test for employment or legal reasons, ensure you disclose your prescription for Diethylpropion to the testing laboratory.

For each major interaction, the mechanism usually involves either direct pharmacodynamic opposition (like with blood pressure meds) or additive stimulation of the sympathetic nervous system. Management usually involves avoiding the combination or frequent monitoring of vital signs.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Do not start any new medication without first consulting your healthcare provider.

In certain clinical situations, the risks of Diethylpropion far outweigh any potential benefit. The drug must NEVER be used in patients with:

• Advanced Arteriosclerosis: Hardening of the arteries can be exacerbated by the drug's effect on blood pressure, increasing the risk of a vascular event.
• Severe Hypertension: Diethylpropion can cause further elevations in blood pressure, potentially leading to hypertensive emergency.
• Hyperthyroidism: The overactive thyroid already stresses the cardiovascular system; adding a sympathomimetic amine can lead to dangerous arrhythmias.
• Glaucoma: Diethylpropion can increase intraocular pressure (the pressure inside the eye), worsening this condition.
• Hypersensitivity/Allergy: Any history of an allergic reaction to Diethylpropion or other sympathomimetic amines (like phentermine).
• Agitated States: Patients who are naturally highly anxious or agitated may experience a severe worsening of these symptoms.
• History of Drug Abuse: Due to its potential for dependence, it is contraindicated in those with a history of substance use disorder.
• MAOI Use: Within 14 days of administration, due to the risk of fatal hypertensive crisis.

These conditions require a careful risk-benefit analysis by a physician:

• Mild Hypertension: Requires very frequent monitoring.
• Diabetes Mellitus: Requires frequent blood sugar checks as weight loss and the drug itself can alter insulin needs.
• Renal Impairment: Increased risk of drug accumulation and toxicity.
• Psychiatric Disorders: Especially those involving mania or psychosis.

Patients who have had an adverse reaction to other stimulant-class drugs, such as phentermine, benzphetamine, or phendimetrazine, are more likely to react poorly to Diethylpropion. There is also a potential for cross-sensitivity with other phenethylamine derivatives used in decongestants (like pseudoephedrine).

> Important: Your healthcare provider will evaluate your complete medical history, including any history of heart disease or mental health issues, before prescribing Diethylpropion.

Diethylpropion is classified as Pregnancy Category B (under the older FDA system). This means that animal reproduction studies have failed to demonstrate a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women. Because weight loss offers no potential benefit to a pregnant woman and may result in fetal harm, Diethylpropion is generally not recommended during pregnancy. If you become pregnant while taking this medication, contact your doctor immediately to discuss discontinuation.

Diethylpropion and its metabolites are known to be excreted in human milk. Because of the potential for serious adverse reactions in nursing infants (such as irritability, sleep disturbances, and increased heart rate), a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother. Most healthcare providers recommend avoiding this medication while breastfeeding.

As previously noted, Diethylpropion is not approved for use in children under 16 years of age. The risk of CNS stimulation, potential for abuse, and the lack of long-term safety data in developing bodies make it an inappropriate choice for pediatric weight management. In older adolescents (16-17), it should only be used under the supervision of a pediatric obesity specialist.

Patients over the age of 65 should use Diethylpropion with extreme caution. This population is more likely to have underlying cardiovascular disease, decreased kidney function, and is often taking multiple other medications (polypharmacy). The risk of drug-induced hypertension and arrhythmias is significantly higher in the elderly. Low starting doses and frequent monitoring of heart and kidney function are mandatory.

There is no specific 'dose-by-GFR' table for Diethylpropion, but since the kidneys are the primary route of excretion, impairment leads to higher blood levels of the drug and its metabolites. In patients with a GFR below 30 mL/min, the drug should be used with extreme caution, and in end-stage renal disease (ESRD), it is generally avoided. It is not known if Diethylpropion is cleared by hemodialysis.

While the drug is metabolized in the liver, clinical data in patients with hepatic impairment is lacking. Patients with significant liver disease (Child-Pugh Class B or C) should be monitored for signs of excessive CNS stimulation, which could indicate that the drug is not being metabolized correctly.

> Important: Special populations require individualized medical assessment. Always inform your doctor about your age, pregnancy status, and any organ-specific health issues.

Diethylpropion is a sympathomimetic amine whose primary pharmacological activity is the stimulation of norepinephrine release from storage granules in the nerve terminals of the hypothalamus. Specifically, it acts on the lateral hypothalamic feeding center to suppress appetite. While it is structurally related to amphetamine, its mechanism is more selective for norepinephrine than for dopamine, which accounts for its lower (though not absent) potential for euphoria and addiction.

The onset of appetite suppression typically occurs within 1 to 2 hours of an oral dose. The duration of effect for the immediate-release form is approximately 4 hours, whereas the controlled-release form provides effects for up to 12 hours. Tolerance to the anorectic effect usually develops within a few weeks of continuous use. When tolerance occurs, the 'maximum' effect has been reached, and the drug should be discontinued rather than increasing the dose, as higher doses do not restore the weight-loss effect but do increase the risk of toxicity.

| Parameter | Value |

|---|---|

| Bioavailability | Rapidly absorbed (>90%) |

| Protein Binding | Minimal (exact % not clinically defined) |

| Half-life | 4–8 hours (active metabolites) |

| Tmax | 1–2 hours (IR); 4–6 hours (CR) |

| Metabolism | Hepatic (N-dealkylation to active metabolites) |

| Excretion | Renal (75%–100%) |

• Molecular Formula: C13H19NO (as Diethylpropion base)
• Molecular Weight: 205.30 g/mol (base); 241.76 g/mol (HCl salt)
• Solubility: Soluble in water and alcohol.
• Structure: Diethylpropion is 2-(diethylamino)propiophenone. It contains a phenyl ring attached to a propanone chain with a diethylated amino group.

Diethylpropion is classified as an Anorectic and a Sympathomimetic Amine. It is a Schedule IV controlled substance under the Controlled Substances Act. Related medications in the same therapeutic class include phentermine, phendimetrazine, and benzphetamine.